Simone Song - Senior Partner and Founding Partner @ ORI Capital

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	CG Oncology	ORI Capital	Yes	Series E - CG Oncology	obfuscated obfuscation
obfuscated obfuscation	AffyImmune Therapeutics	ORI Capital	Yes	Series A - AffyImmune Therapeutics	obfuscated obfuscation
obfuscated obfuscation	CG Oncology	ORI Capital	No	Series D - CG Oncology	obfuscated obfuscation
obfuscated obfuscation	Pillar Biosciences	ORI Capital	Yes	Series C - Pillar Biosciences	obfuscated obfuscation
obfuscated obfuscation	CG Oncology	ORI Capital	Yes	Series C - CG Oncology	obfuscated obfuscation
obfuscated obfuscation	Orchard Therapeutics	ORI Capital	Yes	Series B - Orchard Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Enable Injections	ORI Capital	Yes	Series A - Enable Injections	obfuscated obfuscation
obfuscated obfuscation	Pillar Biosciences	ORI Capital	Yes	Venture Round - Pillar Biosciences	obfuscated obfuscation

Number of Current Jobs

is the

Senior Partner and Founding Partner

Number of Current Board & Advisor Roles

holds

board and advisor roles including

Chairperson of Board

Board Member

, and

Board of Directors

Hub Name	CB Rank (Hub)
Asia-Pacific (APAC) Female Founded Venture Capital Investors	18,600
Hong Kong Female Founded Investors	84,740
Asia Female Founded Investors	7,429
Hong Kong Investors	20,293
Asia-Pacific (APAC) Female Founded Late Stage Venture Investors	37,063
Hong Kong Early Stage Venture Investors	38,901
Asia-Pacific (APAC) Female Founded Investors	9,819
Hong Kong Late Stage Venture Investors	80,045
Asia Investors with Funds Raised in 2021	25,535
Asia Female Founded Late Stage Venture Investors	23,109